CD1922CART细胞序贯治疗儿童

　治疗白癜风哪里好 http://baidianfeng.39.net/
JingPan,1ShiyuZuo,2BipingDeng,3XiuwenXu,4ChuoLi,2QinlongZheng,4ZhuojunLing,5WeiliangSong,5JinlongXu,5JiajiaDuan,5ZelinWang,5XinjianYu,4AlexH.Chang,6XiaomingFeng,2,7andChunrongTong51StateKeyLaboratoryofExperimentalHematology,BeijingBorenHospital,Beijing,China;2StateKeyLaboratoryofExperimentalHematology,NationalClinicalResearchCenterforBloodDiseases,InstituteofHematologyBloodDiseasesHospital,ChineseAcademyofMedicalSciencesPekingUnionMedicalCollege,Tianjin,China;3CytologyLaboratory,4MedicalLaboratory,and5DepartmentofHematology,BeijingBorenHospital,Beijing,China;6ClinicalTranslationalResearchCenter,ShanghaiPulmonaryHospital,TongjiUniversitySchoolofMedicine,Shanghai,China;and7CentralLaboratory,FujianMedicalUniversityUnionHospital,Fuzhou,China执行主编：吴德沛医院翻译：闫志凌医院血液科审校：徐开林医院血液科点评：徐开林医院血液科全文临床试验显示，CD19或CD22嵌合抗原受体（chimericantigenreceptor,CAR）T细胞治疗难治或复发性急性B淋巴细胞白血病（refractoryorrelapsedBacutelymphoblasticleukemia,r/rB-ALL）的完全缓解（